Clinical Trial Update: CXD101 in Immunotherapy-related Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of CXD101 for hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• CXD101

Snippet

Sponsor: Stephen Chan Lam | Conditions: HCC | Phase 2 | Status: RECRUITING